Latest Breaking News On - Jennifer kayden lee - Page 1 : comparemela.com

Needham & Company LLC Reaffirms Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)

Needham & Company LLC reissued their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research note published on Friday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. RYTM has been the subject of a number of other reports. Wells Fargo & Company boosted their target […]

Jennifer kayden leeJoseph shulmanInstitutional trading of rhythm pharmaceuticalsRhythm pharmaceuticals company profileRhythm pharmaceuticals incNeedham companyNews ratings for rhythm pharmaceuticals dailySecurities exchange commissionGoldman sachs groupRhythm pharmaceuticals price performanceMorgan stanleyNisa investment advisorsWhittier trust coChina universal asset management coWells fargo companyRhythm pharmaceuticals

Rhythm Pharmaceuticals' (RYTM) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities research analysts have also recently issued reports on RYTM. Wells Fargo & […]

Recursos ltdaJennifer kayden leeJoseph shulmanRhythm pharmaceuticalsWells fargo companyChina universal asset management coAnalyst recommendations for rhythm pharmaceuticalsNeedham companyInstitutional trading of rhythm pharmaceuticalsNews ratings for rhythm pharmaceuticals dailyGoldman sachs groupInsider activity at rhythm pharmaceuticalsWhittier trust coMorgan stanleyNisa investment advisorsRhythm pharmaceuticals company profile

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $45.43

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $45.43
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jennifer kayden leeHunterc smithInstitutional investors weigh in on rhythm pharmaceuticalsRhythm pharmaceuticalsChina universal asset management coSg americas securitiesWells fargo companyNews ratings for rhythm pharmaceuticals dailyAnalyst recommendations for rhythm pharmaceuticalsNational bankGoldman sachs groupRhythm pharmaceuticals incNeedham companyRhythm pharmaceuticals stockMorgan stanleyGet free report

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $45.43 Consensus Target Price from Brokerages

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $45.43 Consensus Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Joseph shulmanJennifer kayden leeRhythm pharmaceuticalsRhythm pharmaceuticals tradingNational bankGoldman sachs groupNews ratings for rhythm pharmaceuticals dailyChina universal asset management coSg americas securitiesWells fargo companyNeedham companyAnalyst recommendations for rhythm pharmaceuticalsInstitutional trading of rhythm pharmaceuticalsRhythm pharmaceuticals incRhythm pharmaceuticals company profileMorgan stanley

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.1%

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph shulmanJennifer kayden leeLife insurance coRhythm pharmaceuticals incChicago partners investment groupNeedham companyRhythm pharmaceuticalsRhythm pharmaceuticals tradingInstitutional investors weigh in on rhythm pharmaceuticalsWells fargo companyMorgan stanleyGoldman sachs groupRhythm pharmaceuticals company profileChina universal asset management coAllspring global investments holdings